Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation
- PMID: 7074612
Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation
Abstract
Hepatocellular altered foci were induced in rat liver by cycles of feeding of N-2-fluorenylacetamide and were distinguished by their resistance to iron accumulation following production of hepatic siderosis by dietary administration of 8-hydroxyquinoline and ferrous gluconate. The foci were readily identified by their iron exclusion in plastic-embedded sections stained for iron. Sections from iron-free regions processed for electron microscopy permitted ultrastructural study of cells in foci identified by reduced cytoplasmic ferritin. Altered foci of the eosinophilic type produced by cyclic feeding of carcinogen for 16 weeks were composed of both normal-appearing hepatocytes and others with ultrastructural abnormalities, including increased agranular reticulum with associated glycogen particles, decreased rough endoplasmic reticulum with reduced length of cisternae, degranulated rough vesicles, altered and displaced Golgi complexes, and abnormal bile canaliculi. At 12 and 24 weeks after cessation of carcinogen exposure, cells in persistent eosinophilic foci continued to display ultrastructural abnormalities. They possessed increased rough endoplasmic reticulum with rather regular cisternal arrangement and relatively increased smooth endoplasmic reticulum. Golgi complexes were abnormal. Bile canaliculi were abnormal and occasionally increased in number. Nuclei displayed prominent nucleoli. Cells in a basophilic focus were characterized by the presence of numerous free polyribosomes diffusely scattered throughout the cytoplasm, distended rough endoplasmic reticulum with loss of parallel-stack and hypertrophic dilated Golgi complexes, and prominent marginated nucleoli. The finding that persistent foci continued to display ultrastructural abnormalities, some of which changed or progressed in the absence of further carcinogen exposure, suggests that the persistent iron-excluding foci are a permanently altered population.
Similar articles
-
Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.J Natl Cancer Inst. 1978 Nov;61(5):1311-4. J Natl Cancer Inst. 1978. PMID: 280716
-
Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.J Natl Cancer Inst. 1979 Nov;63(5):1257-65. J Natl Cancer Inst. 1979. PMID: 291752
-
Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.J Natl Cancer Inst. 1978 Jul;61(1):113-21. doi: 10.1093/jnci/61.1.113. J Natl Cancer Inst. 1978. PMID: 276621
-
Ultrastructure of hepatocellular tumors.J Toxicol Environ Health. 1979 Mar-May;5(2-3):403-33. J Toxicol Environ Health. 1979. PMID: 224204 Review.
-
Brain iron homeostasis.Dan Med Bull. 2002 Nov;49(4):279-301. Dan Med Bull. 2002. PMID: 12553165 Review.
Cited by
-
Iron metabolism in a mouse model of hepatocellular carcinoma.Sci Rep. 2025 Jan 16;15(1):2180. doi: 10.1038/s41598-025-86486-x. Sci Rep. 2025. PMID: 39820815 Free PMC article.
-
Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.Toxicol Sci. 2011 Oct;123(2):433-40. doi: 10.1093/toxsci/kfr193. Epub 2011 Jul 23. Toxicol Sci. 2011. PMID: 21785164 Free PMC article.
-
Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma.Cancer Sci. 2012 Apr;103(4):767-74. doi: 10.1111/j.1349-7006.2011.02192.x. Epub 2012 Jan 29. Cancer Sci. 2012. PMID: 22181812 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical